0
Clinical Investigations: POSITIVE PRESSURE |

Effects of Training With Heliox and Noninvasive Positive Pressure Ventilation on Exercise Ability in Patients With Severe COPD*

James E. Johnson, MD; Daniel J. Gavin, MD, MAJ USAR, MC; Stacy Adams-Dramiga, MA
Author and Funding Information

*From Cardiopulmonary Rehabilitation (Dr. Johnson), University of Alabama at Birmingham, Birmingham, AL; and the Departments of Pulmonary and Critical Care Medicine (Dr. Gavin) and Cardiopulmonary Rehabilitation (Ms. Adams-Dramiga), Brooke Army Medical Center, Fort Sam Houston, TX.

Correspondence to: James E. Johnson, MD, Pulmonary and Critical Care Division, UAB Hospital, THT 215, 1500 Third Ave S, Birmingham, AL 35294-0006; e-mail: jjohnson@pulm.dom. uab.edu



Chest. 2002;122(2):464-472. doi:10.1378/chest.122.2.464
Text Size: A A A
Published online

Study objectives: We sought to determine whether breathing heliox or using nasal noninvasive positive pressure ventilation (NIPPV) would produce immediate improvements in exercise capability in patients with COPD, and whether training for 6 weeks with one of these modalities would result in greater exercise improvement than with training unassisted.

Setting: US military medical center.

Methods: Thirty-nine patients with severe COPD (mean FEV1 of 33.5% predicted) underwent three incremental treadmill tests to exhaustion unassisted, breathing heliox, or breathing with NIPPV. They were then randomized to undergo 6 weeks of twice-weekly rehabilitation with unassisted exercise training (UT group), training while breathing heliox (HT group), or training while breathing with NIPPV (NT group). The three exercise tests were then repeated.

Results: Heliox treatment did not produce any immediate benefit in exercise time or maximum workload in the 39 patients initially tested, the 32 patients who completed the protocol, or the HT group. Furthermore, no training advantage was evident in the HT group (n = 10) compared to the UT group (n = 11). NIPPV did not produce an immediate benefit in the initial tests, but produced a small increase in exercise time in the 32 patients completing the protocol in the final tests. This effect was primarily because of the NT group, who exercised significantly longer (mean ± SD, 16.8 ± 4.9 min vs 14.2 ± 5.6 min, p = 0.0045) and to a higher workload (4.46 ± 1.55 metabolic equivalents [METs] vs 4.09 ± 1.75 METs, respectively; p = 0.038) when tested using the ventilator. Compared to the UT group, the NT group started out with a lower exercise time (7.9 ± 3.5 min vs 12.3 ± 5.2 min, p = 0.031) in preliminary testing, but the statistical difference was eliminated in the final tests (14.2 ± 5.6 min vs 16.0 ± 5.8 min, respectively; p = 0.451). The NT group actually slightly exceeded the UT group when they used the ventilator in final testing, although this was not statistically significant (16.8 ± 4.9 min vs 16.0 ± 5.8 min, respectively).

Conclusion: Heliox treatment does not appear to offer an immediate or training advantage with exercise in patients with COPD. For patients who have undergone regular exercise conditioning with NIPPV, use of the ventilator produces an immediate improvement in both exercise time and maximum workload attained, and it may confer a training advantage.

Figures in this Article

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
CHEST Journal Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543